Optimal drug treatment of systolic hypertension in the elderly

Area of Science:

• Gerontology
• Cardiology
• Pharmacology

Background:

• Isolated systolic hypertension (ISH) is highly prevalent in the elderly, affecting approximately two-thirds of this population.
• Despite proven benefits of ISH treatment in reducing mortality and stroke, clinical control remains suboptimal in older adults.

Purpose of the Study:

• To provide a practical, clinically focused review of drug treatments for ISH in the elderly.
• To summarize international recommendations and explore newer therapeutic strategies for ISH management in older individuals.

Main Methods:

• Review of pathophysiological changes in elderly subjects relevant to hypertension.
• Analysis of evidence from epidemiological surveys and randomized controlled trials.
• Synthesis of international hypertension management guidelines.

Main Results:

• Thiazide(-like) diuretics and long-acting dihydropyridine calcium channel antagonists are identified as first-line agents for ISH treatment in the elderly.
• Current American, European, and international guidelines support these drug classes for optimal ISH management.
• Novel combination therapies, particularly dihydropyridine calcium channel blockers with ACE inhibitors, demonstrate enhanced efficacy and tolerability.
• Nitrates offer an additional unconventional treatment option when added to existing antihypertensive regimens.

Conclusions:

• Optimal management of isolated systolic hypertension in the elderly relies on established drug classes like thiazide diuretics and calcium channel blockers.
• Emerging combination therapies and the judicious use of nitrates provide valuable advancements in treating ISH in older populations.
• Adherence to international guidelines remains crucial for effective ISH control in the elderly.